POLYCYSTIC OVARIAN DISORDER

Roopa Sharma

ISBN 10: 6209417787 / ISBN 13: 9786209417788

Published by LAP Lambert Academic Publishing, 2026

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -Polycystic Ovarian Disorder (PCOD) is a complex endocrine disorder marked by anovulation, hyperandrogenism, hormonal imbalance, and polycystic ovaries. PCOD affects 5-15% of women who are of reproductive age and is linked to metabolic disorders like obesity, insulin resistance, and an elevated risk of cardiovascular illnesses. Oral contraceptives, insulin sensitisers like metformin, ovulation-inducing agents like clomiphene citrate and letrozole, and anti-androgenic medications are the mainstays of current allopathic management. Emerging nanoformulations of natural and synthetic medicines (such as curcumin, metformin, myo-inositol, selenium, and zinc oxide) represent a viable avenue for customised PCOD treatment. 84 pp. Englisch.

Seller Inventory # 9786209417788

Bibliographic Details

• Title: POLYCYSTIC OVARIAN DISORDER
• Publisher: LAP Lambert Academic Publishing
• Publication Date: 2026
• Language: English
• ISBN 10: 6209417787
• ISBN 13: 9786209417788
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 33D millimeters 220 millimeters width by 150 millimeters height by 33 millimeters depth

About this title

Synopsis

Polycystic Ovarian Disorder (PCOD) is a complex endocrine disorder marked by anovulation, hyperandrogenism, hormonal imbalance, and polycystic ovaries. PCOD affects 5-15% of women who are of reproductive age and is linked to metabolic disorders like obesity, insulin resistance, and an elevated risk of cardiovascular illnesses. Oral contraceptives, insulin sensitisers like metformin, ovulation-inducing agents like clomiphene citrate and letrozole, and anti-androgenic medications are the mainstays of current allopathic management. Emerging nanoformulations of natural and synthetic medicines (such as curcumin, metformin, myo-inositol, selenium, and zinc oxide) represent a viable avenue for customised PCOD treatment.